NCT04998344View on ClinicalTrials.gov

An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

3,800

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Influenza Viral Infections
Interventions
BIOLOGICAL

Inactivated influenza vaccine

Vaccines will be administered as a single dose regimen for the pregnant women and two doses for children at 28-day interval as recommended by the vaccine manufacturers.

BIOLOGICAL

Inactivated polio vaccine

Vaccines will be administered as a single dose regimen for the pregnant women and two doses for children at 28-day interval as recommended by the vaccine manufacturers.

Trial Locations (2)

Unknown

International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka

Norwegian University of Science and Technology, Trondheim

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Norwegian University of Science and Technology

OTHER

lead

University of Bergen

OTHER